Correction to: Development and haematotoxicological evaluation of doped hydroxyapatite based multimodal nanocontrast agent for near-infrared, magnetic resonance and X-ray contrast imaging (Nanotoxicology, (2012), 6, 6, (652-666), 10.3109/17435390.2011.600839);Development and haematotoxicological evaluation of doped hydroxyapatite based multimodal nanocontrast agent for near-infrared, magnetic resonance and X-ray contrast imaging

Nanotoxicology

Volumn 6, Issue 6, 2012, Pages 652-666

  Ashokan, Anusha ^a   Chandran, Parwathy ^a   Sadanandan, Aparna R ^a   Koduri, Chaitanya K ^a   Retnakumari, Archana P ^a   Menon, Deepthy ^a   Nair, Shantikumar ^a   Koyakutty, Manzoor ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Haematotoxicity; Hydroxyapatite nanoparticles; MRI; Near infrared imaging; X ray contrast

Indexed keywords

CONTRAST MEDIUM; HYDROXYAPATITE; INDOCYANINE GREEN; NANOPARTICLE; CYTOKINE; GADOLINIUM;

ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING TIME; BLOOD COMPATIBILITY; BLOOD TOXICITY; CELL VIABILITY; CYTOTOXICITY; HEMATOLOGICAL PARAMETERS; HEMOLYSIS; HUMAN; HUMAN CELL; LYMPHOCYTE; NEAR INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOGRAPHY; STEM CELL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; X RAY ABSORPTION SPECTROSCOPY; ADULT STEM CELL; BLOOD CLOTTING; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; FLOW CYTOMETRY; INFLAMMATION; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; MONONUCLEAR CELL; PH;

ADULT STEM CELLS; BLOOD COAGULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTRAST MEDIA; CYTOKINES; DURAPATITE; FLOW CYTOMETRY; GADOLINIUM; HEMOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STROMAL CELLS; MOLECULAR IMAGING; NANOPARTICLES; PLATELET ACTIVATION; PLATELET AGGREGATION; RADIOGRAPHY; SPECTROSCOPY, NEAR-INFRARED;

EID: 84866652812     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.1080/17435390.2019.1669303     Document Type: Erratum

References (57)

1. Albrecht T, Dawson P. 2000. Gadolinium-DTPA as X-ray contrast medium in clinical studies. Br J Radiol 73:878-882 (Pubitemid 30670286)
2. Altinoglu EI, Russin TJ, Kaiser JM, Barth BM, Eklund PC, Kester M, Adair JH. 2008. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. ACS Nano 2:2075-2084
3. Ashokan A, Menon D, Nair S, Koyakutty M. 2010. A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent. Biomaterials 31:2606-2616
4. Barth BM, Sharma R, Altinoglu EI, Morgan TT, Shanmugavelandy SS, Kaiser JM, et al. 2010. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo. ACS Nano 4:1279-1287
5. Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME. 2007. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA 104:15549-15554 (Pubitemid 47502954)
6. Carr DH, Brown J, Bydder GM, Steiner RE, Weinmann HJ, Speck U, et al. 1984. Gadolinium DTPA as a contrast agent in MRI: Initial clinical experience in 20 patients. Am J Roentgenol 143:215-224 (Pubitemid 14051280)
7. Choi JS, Jun YW, Yeon SI, Kim HC, Shin JS, Cheon J. 2006. Biocompatible heterostructured nanoparticles for multimodal biological detection. J Am Chem Soc 128:15982-15983 (Pubitemid 44936560)
8. Cormode DP, Skajaa T, van Schooneveld MM, Koole R, Jarzyna P, Lobatto ME, et al. 2008. Nanocrystal core high-density lipoproteins: A multimodality contrast agent platform. Nano Lett 8: 3715-3723
9. Derfus AM, Chan WCW, Bhatia SN. 2004. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 4:11-18 (Pubitemid 38167855)
10. Devoisselle JM, Soulie-Begu S,Mordon S, Desmettre T, Maillols H. 1998. A preliminary study of the in vivo behavior of an emulsion formulation of indocyanine green. Laser Med Sci 13:279-282 (Pubitemid 29012290)
11. Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. 2008. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487-495
12. Dobrovolskaia MA, McNeil SE. 2007. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2:469-478 (Pubitemid 47220069)
13. Edward M, Quinn JA, Burden AD, Newton BB, Jardine AG. 2010. Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation. Radiology 256:735-743
14. Ersoy H, Rybicki FJ. 2007. Biochemical safety profiles of gadoliniumbased extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 26:1190-1197 (Pubitemid 350058285)
15. Geys J, Nemmar A, Verbeken E, Smolders E, Ratoi M, Hoylaerts MF, et al. 2008. Acute toxicity and prothrombotic effects of quantum dots: Impact of surface charge. Environ Health Perspect 116:1607-1613
16. Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI. 2007. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: Effect of particle composition. Environ Health Perspect 115:403-409 (Pubitemid 46554439)
17. Goldsby RA, Kindt TJ, Osborne BA, Kuby J. 2003. Immunology. 5th ed. New York: W.H. Freeman and company.pp 236
18. Harboe M. 1959. A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry. Scand J Clin Lab Invest 11:66-70
19. Hope TA, Herfkens RJ, Denianke KS, LeBoit PE, Hung YY, Weil E. 2009. Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine. Invest Radiol 44:135-139
20. Jaffer FA, Libby P, Weissleder R. 2009. Optical and multimodality molecular imaging: Insights into atherosclerosis. Arterioscler Thromb Vasc Biol 29:1017-1024
21. Jevprasesphant R, Penny J, Jalal R, Attwood D, McKeown NB, D'Emanuele A. 2003. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm 252:263-266 (Pubitemid 36126635)
22. John AE, Lukacs NW, Berlin AA, Palecanda A, Bargatze RF, Stoolman LM, Nagy JO. 2003. Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease. FASEB J 17:2296-2298 (Pubitemid 39561471)
23. Kester M, Heakal Y, Fox T, Sharma A, Robertson GP, Morgan TT, et al. 2008. Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Lett 8:4116-4121
24. Kim JS, Rieter WJ, Taylor KM, An H, Lin W, Lin W. 2007. Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging. J Am Chem Soc 129:8962-8963 (Pubitemid 47171835)
25. Kim J, Lee JE, Lee SH, Yu JH, Lee JH, Park TG, Hyeon T. 2008. Designed Fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Adv Mater 20:478-483
26. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L. 2003. A multimodal nanoparticle for pre-operative magnetic resonance imaging and intra-operative optical brain tumor delineation. Cancer Res 63:8122-8125 (Pubitemid 37549457)
27. Lee JH, Jun YW, Yeon SI, Shin JS, Cheon J. 2006. Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma. Angew Chem Int Ed Engl 45:8160-8162 (Pubitemid 44974152)
28. Li C, Penet MF, Winnard P Jr, Artemov D, Bhujwalla ZM. 2008. Image-guided enzyme/prodrug cancer therapy. Clin Cancer Res 14:515-522 (Pubitemid 351226121)
29. Malicka J, Gryczynski I, Geddes CD, Lakowicz Jr. 2003. Metal-enhanced emission from indocyanine green: A new approach to in vivo imaging. J Biomed Opt 8:472-478
30. Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Fröhlich E. 2009. The role of nanoparticle size in hemocompatibility. Toxicology 258:139-147
31. Miller VM, Hunter LW, Chu K, Kaul V, Squillace PD, Lieske JC, Jayachandran M. 2009. Biologic nanoparticles and platelet reactivity. Nanomedicine (Lond) 4:725-733
32. Mondejar SP, Kovtun A, Epple M. 2007. Lanthanide-doped calcium phosphate nanoparticles with high internal crystallinity and with a shell of DNA as fluorescent probes in cell experiments. J Mater Chem 17:4153-4159 (Pubitemid 47512925)
33. Moore A, Medarova Z, Potthast A, Dai G. 2004. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res 64:1821-1827 (Pubitemid 38428707)
34. Morgan TT, Muddana HS, Altinoglu EI, Rouse SM, Tabakovic A, Tabouillot T, et al. 2008. Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery. Nano Lett 8:4108-4115
35. Mulder WJ, Koole R, Brandwijk RJ, Storm G, Chin PT, Strijkers GJ, et al. 2006. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett 6:1-6 (Pubitemid 43166093)
36. Pattani A, Patravale VB, Panicker L, Potdar PD. 2009. Immunological effects and membrane interactions of chitosan nanoparticles. Mol Pharm 6:345-352
37. Pettibone JM, Dodd AA, Thorne PS, O'Shaughnessy PT, Weydert JA, Grassian VH. 2008. Inflammatory response of mice following inhalation exposure to iron and copper nanoparticles. Nanotoxicology 2:189-204 (Pubitemid 352790871)
38. Philip R, Penzkofer A, Baumler W, Szeimies RM, Abels C. 1996. Absorption and fluorescence spectroscopic investigation of indocyanine green. J Photochem Photobiol A 96:137-148 (Pubitemid 126171156)
39. Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, Radomski MW. 2005. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 146: 882-893 (Pubitemid 41622255)
40. Remy-Jardin M, Bahepar J, Lafitte JJ, Dequiedt P, Ertzbischoff O, Bruzzi J, et al. 2006. Multi-detector row CT angiography of pulmonary circulation with gadolinium-based contrast agents: Prospective evaluation in 60 patients. Radiology 238: 1022-1035 (Pubitemid 43289935)
41. Rieter WJ, Kim JS, Taylor KM, An H, Lin W, Tarrant T, Lin W. 2007. Hybrid silica nanoparticles for multimodal imaging. Angew Chem Int Ed Engl 46:3680-3682 (Pubitemid 46981247)
42. Sahli H, Tapon-Bretaudiere J, Fischer AM, Sternberg C, Spenlehauer G, Verrecchia T, Labarre D. 1997. Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system. Biomaterials 18:281-288 (Pubitemid 27073047)
43. Santra S, Bagwe RP, Dutta D, Stanley JT, Walter GA, Tan W, et al. 2005. Synthesis and characterization of fluorescent, radio-Opaque, and paramagnetic silica nanoparticles for multimodal bioimaging applications. Adv Mater 17:2165-2169 (Pubitemid 41338513)
44. Semberova J, De Paoli Lacerda SH, Simakova O, Holada K, Gelderman MP, Simak J. 2009. Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors. Nano Lett 9:3312-3317
45. Shaunak S, Thomas S, Gianasi E, Godwin A, Jones E, Teo I, et al. 2004. Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat Biotechnol 22:977-984 (Pubitemid 39014474)
46. Sinha D, Seaman FS, Walsh PN. 1987. Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX. Biochemistry 26:3768-3775 (Pubitemid 17127449)
47. Sokolova VV, Radtke I, Heumann R, Epple M. 2006. Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles. Biomaterials 27:3147-3153 (Pubitemid 43247588)
48. Sokolova V, Kovtun A, Prymak O, Meyer-Zaika W, Kubareva EA, Romanova EA, et al. 2007. Functionalisation of calcium phosphate nanoparticles by oligonucleotides and their application for gene silencing. J Mater Chem 17:721-727
49. Strijkers GJ, Kluza E, Van Tilborg GA, van der Schaft DW, Griffioen AW, Mulder WJ, Nicolay K. 2010. Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis. Angiogenesis 13:161-173
50. Tavano R, Segat D, Reddi E, Kos J, Rojnik M, Kocbek P, et al. 2010. Procoagulant properties of bare and highly PEGylated vinylmodified silica nanoparticles. Nanomedicine (Lond) 5:881-896
51. Tiwari DK, Jin T, Behari J. 2011. Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol Mech Methods 21:13-24
52. Vizard DL, Wood DO, Papineni RV, Feke GD, Orton SP, McLaughlin WE. 2010. Analytical radiography for planar radiographic images implemented with a multi-modal system. Comput Methods Programs Biomed 99:88-97
53. Wang W, Xiong W, Zhu Y, Xu H, Yang X. 2010. Protective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells. J Biomed Mater Res B Appl Biomater 93:59-64
54. Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L. 2005. Cellspecific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 23:1418-1423 (Pubitemid 41679395)
55. Woodard JR, Hilldore AJ, Lan SK, Park CJ, Morgan AW, Eurell JA, et al. 2007. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials 28: 45-54 (Pubitemid 44427902)
56. Wu HC, Wang TW, Sun JS, Wang WH, Lin FH. 2007. A novel biomagnetic nanoparticle based on hydroxyapatite. Nanotechnology 18:165601
57. Yu J, Yaseen MA, Anvari B, Wong MS. 2007. Synthesis of near-infrared-absorbing nanoparticle-assembled capsules. Chem Mater 19:1277-1284 (Pubitemid 46507026)